Cyanotech Corporation Announces FY 2006 First Quarter Financial Results Webcast on August 11, 2005.KAILUA KONA, Hawaii -- Cyanotech Corporation (Nasdaq:CYAN), a world leader in producing high-value natural products from microalgae, will announce financial results for the first quarter of fiscal 2006, ended June 30, 2005, after the market closes on Thursday, August 11, 2005. Webcast -- Cyanotech Corporation will hold a conference call in conjunction with the press release. The conference call will be broadcast live over the Internet on Thursday, August 11, 2005 at 5:30 p.m. Eastern Time. It can be accessed by all interested parties by linking through the Investor Broadcast Network's VCall website at www.vcall.com or through Cyanotech's website, www.cyanotech.com. To listen to the live call, please go to either website at least 15 minutes prior to the start of the call to register, download, and install any necessary audio software. Archive -- An archive of the webcast will be available later at www.vcall.com and at www.cyanotech.com Questions -- In advance of the webcast, Cyanotech welcomes investors to submit questions by email to brucerussell@ruscom.com and will address those questions as possible during the webcast. About Cyanotech -- Cyanotech Corporation, a world leader in microalgal technology, produces BioAstin(R) natural astaxanthin and Spirulina spirulina Any cyanobacteria in the genus Spirulina. A traditional food source in parts of Africa and Mexico, spirulina is an exceptionally rich source of vitamins, minerals, and protein, and one of the few nonanimal sources of vitamin B12. Pacifica(R) -- all-natural, functional nutrients that enhance human health and nutrition, providing significant antioxidant antioxidant, substance that prevents or slows the breakdown of another substance by oxygen. Synthetic and natural antioxidants are used to slow the deterioration of gasoline and rubber, and such antioxidants as vitamin C (ascorbic acid), butylated hydroxytoluene , anti-inflammatory and immune response immune response n. An integrated bodily response to an antigen, especially one mediated by lymphocytes and involving recognition of antigens by specific antibodies or previously sensitized lymphocytes. benefits. The Company's other compounds, such as NatuRose(R) natural astaxanthin, promote animal nutrition and health, primarily in aquaculture aquaculture, the raising and harvesting of fresh- and saltwater plants and animals. The most economically important form of aquaculture is fish farming, an industry that accounts for an ever increasing share of world fisheries production. . Cyanotech extracts these compounds from microalgae grown at its 90-acre facility in Hawaii using proprietary processes, and distributes them to nutraceutical, nutritional supplement, cosmeceutical cos·me·ceu·ti·cal n. A cosmetic that has or is purported to have medicinal properties. and aquaculture feed makers and marketers worldwide. Corporate data and product information are available at www.cyanotech.com. "Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. " Statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995 Except for statements of historical fact, the statements in this press release are forward-looking. Such statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include, but are not limited to, general economic conditions, forecasts of sales in future periods, changes in sales levels to our largest customers, weather patterns, production problems caused by contamination, risks associated with the acceptance of new products, competition, foreign exchange fluctuations, government regulation, and other factors more fully detailed in the Company's recent Form 10-Q Form 10-Q See 10-Q. and annual form 10-K filings with the Securities and Exchange Commission. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion